Miguel Valle

Title: Miguel Valle: Innovator in Recombinant AAV Production

Introduction

Miguel Valle is a prominent inventor based in Potomac, MD (US). He has made significant contributions to the field of biotechnology, particularly in the production of recombinant Adeno-Associated Virus (rAAV) particles. His innovative methods have the potential to enhance the efficiency of gene therapy applications.

Latest Patents

Miguel Valle holds 1 patent for his work titled "Scalable method for recombinant AAV production." This patent outlines improved methods for producing rAAV particles. The method involves culturing cells capable of producing rAAV particles in the presence of a histone deacetylase (HDAC) inhibitor. Additionally, it includes the use of an increased amount of a sodium salt to further enhance production.

Career Highlights

Throughout his career, Miguel Valle has demonstrated a commitment to advancing biotechnological methods. His work at Regenxbio Inc. has positioned him as a key player in the development of innovative solutions for gene therapy. His research focuses on optimizing the production processes for rAAV, which is crucial for effective gene delivery systems.

Collaborations

Miguel has collaborated with notable colleagues, including Michael Gillmeister and Bhargavi Kondragunta. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of biotechnology.

Conclusion

In summary, Miguel Valle is an influential inventor whose work in recombinant AAV production is paving the way for advancements in gene therapy. His innovative methods and collaborations highlight his dedication to improving biotechnological processes.